Multiple viral infections post-hematopoietic stem cell transplantation are linked to the appearance of chronic GVHD among pediatric recipients of allogeneic grafts

Pediatric Transplantation

Volumn 14, Issue 2, 2010, Pages 242-248

  Olkinuora, Helena A ^a   Taskinen, Mervi H ^a   Saarinen Pihkala, Ulla M ^a   Vettenranta, Kim K ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Immunosuppression; Pediatric; Viral infections

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CIDOFOVIR; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OSELTAMIVIR; PREDNISOLONE; RIBAVIRIN; THALIDOMIDE; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ADD ON THERAPY; ADENOVIRUS INFECTION; ALLOGRAFT; ARTICLE; BK VIRUS; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; CONVALESCENCE; CORRELATIONAL STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG MEGADOSE; EVALUATION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN HERPESVIRUS 6; INFECTION RISK; INFLUENZA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PATHOGENESIS; PEDIATRICS; PRESCHOOL CHILD; PROPHYLAXIS; RETROSPECTIVE STUDY; RNA VIRUS INFECTION; SCHOOL CHILD; TREATMENT FAILURE; VIRUS INFECTION; VIRUS REACTIVATION;

CHILD; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; VIRUS DISEASES;

EID: 76449110193     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01226.x     Document Type: Article

References (21)

1. Frassoni F, Labopin M, Gluckman E, et al. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time - A report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant 1996 : 17 : 13 18.
2. Dominietto A, Lamparelli T, Raiola AM, et al. Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation. Blood 2002 : 100 : 3930 3934.
3. Gratwohl A, Brand R, Frassoni F, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: An EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005 : 36 : 757 769.
4. Eapen M, Rubinstein P, Zhang MJ, et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol 2006 : 24 : 145 151.
5. Miller W, Flynn P, McCullough J, et al. Cytomegalovirus infection after bone marrow transplantation: An association with acute graft-v-host disease. Blood 1986 : 67 : 1162 1167.
6. Meyers JD. Infection in bone marrow transplant recipients. Am J Med 1986 : 81 : 27 38.
7. Wasserman R, August CS, Plotkin SA. Viral infections in pediatric bone marrow transplant patients. Pediatr Infect Dis J 1988 : 7 : 109 115.
8. Tutschka PJ. Infections and immunodeficiency in bone marrow transplantation. Pediatr Infect Dis J 1988 : 7 (5 Suppl S22 S29.
9. Ochs L, Shu XO, Miller J, et al. Late infections after allogeneic bone marrow transplantations: Comparison of incidence in related and unrelated donor transplant recipients. Blood 1995 : 86 : 3979 3986.
10. Storek J, Dawson MA, Storer B, et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001 : 97 : 3380 3389.
11. Olkinuora H, Talvensaari K, Kaartinen T, et al. T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2007 : 39 : 149 156.
12. Maltezou HC, Kafetzis DA, Abisaid D, Mantzouranis EC, Chan KW, Rolston KV. Viral infections in children undergoing hematopoietic stem cell transplant. Pediatr Infect Dis J 2000 : 19 : 307 312.
13. Lujan-Zilbermann J, Benaim E, Tong X, Srivastava DK, Patrick CC, DeVincenzo JP. Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin Infect Dis 2001 : 33 : 962 968.
14. Bredius RG, Templeton KE, Scheltinga SA, Claas EC, Kroes AC, Vossen JM. Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients. Pediatr Infect Dis J 2004 : 23 : 518 522.
15. Anderson EJ, Guzman-Cottrill JA, Kletzel M, et al. High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. Pediatr Transplant 2008 : 12 : 219 227.
16. George B, Mathews V, Viswabandya A, Srivastava A, Chandy M. Infections in children undergoing allogeneic bone marrow transplantation in India. Pediatr Transplant 2006 : 10 : 48 54.
17. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004 : 104 : 1923 1930.
18. Anderson EJ. Viral diagnostics and antiviral therapy in hematopoietic stem cell transplantation. Curr Pharm Des 2008 : 14 : 1997 2010.
19. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 2002 : 118 : 44 57.
20. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974 : 18 : 295 304.
21. Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the international bone marrow transplant registry. Bone Marrow Transplant 1989 : 4 : 247 254.